Regulated expression of cofilin and the consequent regulation of p27 kip1 are essential for G1 phase progression

Cell Cycle

Volumn 8, Issue 15, 2009, Pages 2365-2374

  Tsai, Cheng Han ^a   Chiu, Shu Jun ^b   Liu, Chih Chao ^a   Sheu, Tzong Jen ^c   Hsieh, Chia Hung ^d   Keng, Peter C ^e   Lee, Yi Jang ^a,f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^f VGH Taipei   (Taiwan)

Author keywords

Actin cytoskeleton; Cofilin; Cyclin dependent kinase inhibitor; G1 phase arrest; p27kip1

Indexed keywords

COFILIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; DOXYCYCLINE; MESSENGER RNA; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA;

ARTICLE; ASSAY; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; UPREGULATION;

EID: 68449090920     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.15.9072     Document Type: Article

References (56)

1. Kaji N, Ohashi K, Shuin M, Niwa R, Uemura T, Mizuno K. Cell cycle-associated changes in Slingshot phosphatase activity and roles in cytokinesis in animal cells. J Biol Chem 2003; 278:33450-33455 (Pubitemid 37055799)
2. Nagaoka R, Abe H, Obinata T. Site-directed mutagenesis of the phosphorylation site of cofilin: its role in cofilin-actin interaction and cytoplasmic localization. Cell Motil Cytoskeleton 1996; 35:200-209 (Pubitemid 26363866)
3. Abe H, Obinata T, Minamide LS, Bamburg JR. Xenopus laevis actin-depolymerizing factor/cofilin: a phosphorylation-regulated protein essential for development. J Cell Biol 1996; 132:871-885
4. Bellenchi GC, Gurniak CB, Perlas E, Middei S, Ammassari-Teule M, Witke W. N-cofilin is associated with neuronal migration disorders and cell cycle control in the cerebral cortex. Genes Dev 2007; 21:2347-2357 (Pubitemid 47443340)
5. Gunsalus KC, Bonaccorsi S, Williams E, Verni F, Gatti M, Goldberg ML. Mutations in twinstar, a Drosophila gene encoding a cofilin/ADF homologue, result in defects in centrosome migration and cytokinesis. J Cell Biol 1995; 131:1243-1259
6. Gurniak CB, Perlas E, Witke W. The actin depolymerizing factor n-cofilin is essential for neural tube morphogenesis and neural crest cell migration. Dev Biol 2005; 278:231-241 (Pubitemid 40092863)
7. Somma MP, Fasulo B, Cenci G, Cundari E, Gatti M. Molecular dissection of cytokinesis by RNA interference in Drosophila cultured cells. Mol Biol Cell 2002; 13:2448-2460 (Pubitemid 34831347)
8. Bamburg JR, McGough A, Ono S. Putting a new twist on actin: ADF/cofilins modulate actin dynamics. Trends Cell Biol 1999; 9:364-370 (Pubitemid 29447718)
9. Abe H, Ohshima S, Obinata T. A cofilin-like protein is involved in the regulation of actin assembly in developing skeletal muscle. J Biochem 1989; 106:696-702. (Pubitemid 19241841)
10. Gillett GT, Fox MF, Rowe PS, Casimir CM, Povey S. Mapping of human non-muscle type cofilin (CFL1) to chromosome 11q13 and muscle-type cofilin (CFL2) to chromosome 14. Ann Hum Genet 1996; 60:201-211 (Pubitemid 26259347)
11. Hawkins M, Pope B, Maciver SK, Weeds AG. Human actin depolymerizing factor mediates a pH-sensitive destruction of actin filaments. Biochemistry 1993; 32:9985-9993 (Pubitemid 23312424)
12. Wang W, Eddy R, Condeelis J. The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 2007; 7:429-440 (Pubitemid 46809168)
13. Hotulainen P, Paunola E, Vartiainen MK, Lappalainen P. Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in mammalian nonmuscle cells. Mol Biol Cell 2005; 16:649-664 (Pubitemid 40165562)
14. Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E, et al. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004; 64:8585-8594 (Pubitemid 39552071)
15. Helin K, Harlow E, Fattaey A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 1993; 13:6501-6508 (Pubitemid 23292644)
16. Brehm A, Miska E, Reid J, Bannister A, Kouzarides T. The cell cycle-regulating transcription factors E2F-RB. Br J Cancer 1999; 80:38-41. (Pubitemid 29389606)
17. 1-phase progression. Genes Dev 1999; 13:1501-1512
18. Assoian RK. Control of the G1 phase cyclin-dependent kinases by mitogenic growth factors and the extracellular matrix. Cytokine Growth Factor Rev 1997; 8:165-170 (Pubitemid 28077924)
19. Assoian RK, Zhu X. Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr Opin Cell Biol 1997; 9:93-98 (Pubitemid 27065114)
20. Huang S, Chen CS, Ingber DE. Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension. Mol Biol Cell 1998; 9:3179-3193
21. Fasshauer M, Iwig M, Glaesser D. Synthesis of proto-oncogene proteins and cyclins depends on intact microfilaments. Eur J Cell Biol 1998; 77:188-195 (Pubitemid 28529059)
22. Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Exp Cell Res 2000; 259:35-53.
23. Assoian RK. Anchorage-dependent cell cycle progression. J Cell Biol 1997; 136:1-4.
24. Amano T, Kaji N, Ohashi K, Mizuno K. Mitosis-specific activation of LIM motifcontaining protein kinase and roles of cofilin phosphorylation and dephosphorylation in mitosis. J Biol Chem 2002; 277:22093-22102 (Pubitemid 34952364)
25. Lee YJ, Keng PC. Studying the effects of actin cytoskeletal destabilization on cell cycle by cofilin overexpression. Mol Biotechnol 2005; 31:1-10.
26. Lee YJ, Mazzatti DJ, Yun Z, Keng PC. Inhibition of invasiveness of human lung cancer cell line H1299 by overexpression of cofilin. Cell Biol Int 2005; 29:877-883 (Pubitemid 41654790)
27. Kip1 mRNA and protein in murine B cells. J Immunol 1998; 160:770-777
28. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994; 8:9-22.
29. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78:67-74.
30. Keshamouni VG, Michailidis G, Grasso CS, Anthwal S, Strahler JR, Walker A, et al. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res 2006; 5:1143-1154 (Pubitemid 43727792)
31. Wang K, Li J, Zhen C, Zhou J, Xiao D, Liu J, et al. Enhanced invasive and metastatic potential induced by transforming growth factor-beta1 might be correlated with glutathione- S-transferase-pi, cofilin and heat shock protein 27 in SGC-7901 gastric cancer cells. Acta Biochim Biophys Sin (Shanghai) 2007; 39:520-526 (Pubitemid 47117601)
32. Malmstrom J, Lindberg H, Lindberg C, Bratt C, Wieslander E, Delander EL, et al. Transforming growth factor-beta 1 specifically induce proteins involved in the myofibroblast contractile apparatus. Mol Cell Proteomics 2004; 3:466-477 (Pubitemid 38714288)
33. Keshamouni VG, Jagtap P, Michailidis G, Strahler JR, Kuick R, Reka AK, et al. Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGFbeta-Induced epithelial-mesenchymal transition. J Proteome Res 2009; 8:35-47.
34. Keski-Oja J, Blasi F, Leof EB, Moses HL. Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta. J Cell Biol 1988; 106:451-459 (Pubitemid 18052193)
35. Newman MJ. Inhibition of carcinoma and melanoma cell growth by type 1 transforming growth factor beta is dependent on the presence of polyunsaturated fatty acids. Proc Natl Acad Sci USA 1990; 87:5543-5547 (Pubitemid 20260217)
36. Polyak K. Negative regulation of cell growth by TGFbeta. Biochim Biophys Acta 1996; 1242:185-199 (Pubitemid 26106293)
37. 1/S progression during hyperoxia. Am J Physiol Lung Cell Mol Physiol 2004; 286:506-513
38. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78:59-66. (Pubitemid 2117026)
39. Laufs U, Marra D, Node K, Liao JK. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced downregulation of p27(Kip1). J Biol Chem 1999; 274:21926-21931 (Pubitemid 129519746)
40. Kip1 controls its cyclin D-cdk4 inhibitory activity. Mol Cell Biol 2008; 28:498-510.
41. kip1. Exp Cell Res 2002; 280:233-243
42. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 1997; 27:1-20. (Pubitemid 27059777)
43. Rodier G, Montagnoli A, Di Marcotullio L, Coulombe P, Draetta GF, Pagano M, et al. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J 2001; 20:6672-6682 (Pubitemid 33134197)
44. Morisaki H, Fujimoto A, Ando A, Nagata Y, Ikeda K, Nakanishi M. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2. Biochem Biophys Res Commun 1997; 240:386-390 (Pubitemid 27523669)
45. Yahara I, Aizawa H, Moriyama K, Iida K, Yonezawa N, Nishida E, et al. A role of cofilin/destrin in reorganization of actin cytoskeleton in response to stresses and cell stimuli. Cell Struct Funct 1996; 21:421-424 (Pubitemid 27068329)
46. Iida K, Matsumoto S, Yahara I. The KKRKK sequence is involved in heat shock-induced nuclear translocation of the 18-kDa actin-binding protein, cofilin. Cell Struct Funct 1992; 17:39-46.
47. Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 2008; 8:253-267
48. Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004; 18:862-876
49. Kip1 induces cell migration. Nat Med 1998; 4:1449-1452
50. McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol Cell Biol 2003; 23:216-228 (Pubitemid 36008515)
51. Belletti B, Nicoloso MS, Schiappacassi M, Chimienti E, Berton S, Lovat F, et al. p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs. Curr Med Chem 2005; 12:1589-1605
52. Blain SW, Scher HI, Cordon-Cardo C, Koff A. p27 as a target for cancer therapeutics. Cancer Cell 2003; 3:111-115 (Pubitemid 37443384)
53. Price BD, Hughes-Davies L, Park SJ. Cdk2 kinase phosphorylates serine 315 of human p53 in vitro. Oncogene 1995; 11:73-80.
54. Birmingham A, Anderson EM, Reynolds A, Ilsley-Tyree D, Leake D, Fedorov Y, et al. 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 2006; 3:199-204.
55. Jackson AL, Burchard J, Leake D, Reynolds A, Schelter J, Guo J, et al. Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. Rna 2006; 12:1197-1205
56. Inoue T, Kamiyama J, Sakai T. Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements. J Biol Chem 1999; 274:32309-32317